Thermo Fisher Scientific has launched the One Lambda™ HybriType™ HLA Plus Typing Flex kit, a powerful next-generation sequencing (NGS) solution crafted to enhance histocompatibility and immunogenetics research while optimizing lab workflows. Built on a hybrid capture, probe-based design, the system ensures balanced reads and high data uniformity, which helps reduce allele dropout and ambiguity.
Engineered for flexibility and speed, the HybriType assay supports Class I (4-field) and Class II (3-field) HLA genotyping, with coverage of 18 loci, including 11 standard HLA loci and 7 optional MHC loci. Its modular design allows laboratories to customize testing strategies based on specific research needs. Compatible with blood and buccal swab samples, the assay offers exceptional convenience for diverse operational environments.
Designed with lab efficiency in mind, the platform provides results in under 5.5 hours, with less than 2.5 hours of hands-on time. When paired with the TypeStream™ Visual NGS Software, labs can achieve seamless, automated analysis—freeing up valuable staff time and enhancing throughput.
Benefits for Lab Managers Using the HybriType Flex Kit
- Operational Efficiency: Shortens total workflow time to under 5.5 hours.
- Reduced Labor: Less than 2.5 hours of hands-on processing.
- Configurable Assay Content: Modular 18-loci design to meet varying research demands.
- Multi-Sample Compatibility: Handles both whole blood and buccal swab inputs.
- Enhanced Accuracy: ≥99.8% concordance for confident genotyping.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. The original press release was provided by Thermo Fisher Scientific.
